Industry Research Reports
Home > Reports > Chemical & Material > Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Chemical & Material
Published Date: 2024-02-22
Pages: 122 Pages
Report ld: 2555303
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
The global market for Bio-active Peptides was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Bio-active Peptides was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-active Peptides was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bio-active Peptides was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bio-active Peptides include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products and Valio Oy, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
By Company
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep
- Arlak Biotech
- Naturade
- Royal DSM
- MYOS RENS Technology
- Natural Factors Nutritional Products
- Valio Oy
- Wuhan Lullaby Pharmaceutical Chemical
- Wuhan Dahua Pharmaceutical
- Pharma Foods International
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Bio-active Peptides
- Artificial Synthesis Bio-active Peptides
Segment by Application
- Food
- Health Products
- Pharmaceutical
- Other
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Bio-active Peptides, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bio-active Peptides by region & country, by Type, and by Application.
The Bio-active Peptides market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-active Peptides.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bio-active Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bio-active Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bio-active Peptides in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bio-active Peptides Product Introduction
1.2 Global Bio-active Peptides Market Size Forecast
1.2.1 Global Bio-active Peptides Sales Value (2019-2030)
1.2.2 Global Bio-active Peptides Sales Volume (2019-2030)
1.2.3 Global Bio-active Peptides Sales Price (2019-2030)
1.3 Bio-active Peptides Market Trends & Drivers
1.3.1 Bio-active Peptides Industry Trends
1.3.2 Bio-active Peptides Market Drivers & Opportunity
1.3.3 Bio-active Peptides Market Challenges
1.3.4 Bio-active Peptides Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bio-active Peptides Players Revenue Ranking (2023)
2.2 Global Bio-active Peptides Revenue by Company (2019-2024)
2.3 Global Bio-active Peptides Players Sales Volume Ranking (2023)
2.4 Global Bio-active Peptides Sales Volume by Company Players (2019-2024)
2.5 Global Bio-active Peptides Average Price by Company (2019-2024)
2.6 Key Manufacturers Bio-active Peptides Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bio-active Peptides Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bio-active Peptides
2.9 Bio-active Peptides Market Competitive Analysis
2.9.1 Bio-active Peptides Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bio-active Peptides Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-active Peptides as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural Bio-active Peptides
3.1.2 Artificial Synthesis Bio-active Peptides
3.2 Global Bio-active Peptides Sales Value by Type
3.2.1 Global Bio-active Peptides Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bio-active Peptides Sales Value, by Type (2019-2030)
3.2.3 Global Bio-active Peptides Sales Value, by Type (%) (2019-2030)
3.3 Global Bio-active Peptides Sales Volume by Type
3.3.1 Global Bio-active Peptides Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bio-active Peptides Sales Volume, by Type (2019-2030)
3.3.3 Global Bio-active Peptides Sales Volume, by Type (%) (2019-2030)
3.4 Global Bio-active Peptides Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food
4.1.2 Health Products
4.1.3 Pharmaceutical
4.1.4 Other
4.2 Global Bio-active Peptides Sales Value by Application
4.2.1 Global Bio-active Peptides Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bio-active Peptides Sales Value, by Application (2019-2030)
4.2.3 Global Bio-active Peptides Sales Value, by Application (%) (2019-2030)
4.3 Global Bio-active Peptides Sales Volume by Application
4.3.1 Global Bio-active Peptides Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bio-active Peptides Sales Volume, by Application (2019-2030)
4.3.3 Global Bio-active Peptides Sales Volume, by Application (%) (2019-2030)
4.4 Global Bio-active Peptides Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bio-active Peptides Sales Value by Region
5.1.1 Global Bio-active Peptides Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bio-active Peptides Sales Value by Region (2019-2024)
5.1.3 Global Bio-active Peptides Sales Value by Region (2025-2030)
5.1.4 Global Bio-active Peptides Sales Value by Region (%), (2019-2030)
5.2 Global Bio-active Peptides Sales Volume by Region
5.2.1 Global Bio-active Peptides Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bio-active Peptides Sales Volume by Region (2019-2024)
5.2.3 Global Bio-active Peptides Sales Volume by Region (2025-2030)
5.2.4 Global Bio-active Peptides Sales Volume by Region (%), (2019-2030)
5.3 Global Bio-active Peptides Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bio-active Peptides Sales Value, 2019-2030
5.4.2 North America Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bio-active Peptides Sales Value, 2019-2030
5.5.2 Europe Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bio-active Peptides Sales Value, 2019-2030
5.6.2 Asia Pacific Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bio-active Peptides Sales Value, 2019-2030
5.7.2 South America Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bio-active Peptides Sales Value, 2019-2030
5.8.2 Middle East & Africa Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bio-active Peptides Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bio-active Peptides Sales Value
6.2.1 Key Countries/Regions Bio-active Peptides Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bio-active Peptides Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bio-active Peptides Sales Value, 2019-2030
6.3.2 United States Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bio-active Peptides Sales Value, 2019-2030
6.4.2 Europe Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bio-active Peptides Sales Value, 2019-2030
6.5.2 China Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bio-active Peptides Sales Value, 2019-2030
6.6.2 Japan Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bio-active Peptides Sales Value, 2019-2030
6.7.2 South Korea Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bio-active Peptides Sales Value, 2019-2030
6.8.2 Southeast Asia Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bio-active Peptides Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bio-active Peptides Sales Value, 2019-2030
6.9.2 India Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bio-active Peptides Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Archer Daniels Midland Company
7.1.1 Archer Daniels Midland Company Company Information
7.1.2 Archer Daniels Midland Company Introduction and Business Overview
7.1.3 Archer Daniels Midland Company Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Archer Daniels Midland Company Bio-active Peptides Product Offerings
7.1.5 Archer Daniels Midland Company Recent Development
7.2 Seagarden AS
7.2.1 Seagarden AS Company Information
7.2.2 Seagarden AS Introduction and Business Overview
7.2.3 Seagarden AS Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Seagarden AS Bio-active Peptides Product Offerings
7.2.5 Seagarden AS Recent Development
7.3 Phermpep
7.3.1 Phermpep Company Information
7.3.2 Phermpep Introduction and Business Overview
7.3.3 Phermpep Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Phermpep Bio-active Peptides Product Offerings
7.3.5 Phermpep Recent Development
7.4 Arlak Biotech
7.4.1 Arlak Biotech Company Information
7.4.2 Arlak Biotech Introduction and Business Overview
7.4.3 Arlak Biotech Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Arlak Biotech Bio-active Peptides Product Offerings
7.4.5 Arlak Biotech Recent Development
7.5 Naturade
7.5.1 Naturade Company Information
7.5.2 Naturade Introduction and Business Overview
7.5.3 Naturade Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Naturade Bio-active Peptides Product Offerings
7.5.5 Naturade Recent Development
7.6 Royal DSM
7.6.1 Royal DSM Company Information
7.6.2 Royal DSM Introduction and Business Overview
7.6.3 Royal DSM Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Royal DSM Bio-active Peptides Product Offerings
7.6.5 Royal DSM Recent Development
7.7 MYOS RENS Technology
7.7.1 MYOS RENS Technology Company Information
7.7.2 MYOS RENS Technology Introduction and Business Overview
7.7.3 MYOS RENS Technology Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.7.4 MYOS RENS Technology Bio-active Peptides Product Offerings
7.7.5 MYOS RENS Technology Recent Development
7.8 Natural Factors Nutritional Products
7.8.1 Natural Factors Nutritional Products Company Information
7.8.2 Natural Factors Nutritional Products Introduction and Business Overview
7.8.3 Natural Factors Nutritional Products Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Natural Factors Nutritional Products Bio-active Peptides Product Offerings
7.8.5 Natural Factors Nutritional Products Recent Development
7.9 Valio Oy
7.9.1 Valio Oy Company Information
7.9.2 Valio Oy Introduction and Business Overview
7.9.3 Valio Oy Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Valio Oy Bio-active Peptides Product Offerings
7.9.5 Valio Oy Recent Development
7.10 Wuhan Lullaby Pharmaceutical Chemical
7.10.1 Wuhan Lullaby Pharmaceutical Chemical Company Information
7.10.2 Wuhan Lullaby Pharmaceutical Chemical Introduction and Business Overview
7.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Offerings
7.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Development
7.11 Wuhan Dahua Pharmaceutical
7.11.1 Wuhan Dahua Pharmaceutical Company Information
7.11.2 Wuhan Dahua Pharmaceutical Introduction and Business Overview
7.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Offerings
7.11.5 Wuhan Dahua Pharmaceutical Recent Development
7.12 Pharma Foods International
7.12.1 Pharma Foods International Company Information
7.12.2 Pharma Foods International Introduction and Business Overview
7.12.3 Pharma Foods International Bio-active Peptides Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pharma Foods International Bio-active Peptides Product Offerings
7.12.5 Pharma Foods International Recent Development
8 Industry Chain Analysis
8.1 Bio-active Peptides Industrial Chain
8.2 Bio-active Peptides Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bio-active Peptides Sales Model
8.5.2 Sales Channel
8.5.3 Bio-active Peptides Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Bio-active Peptides Market Trends
Table 2. Bio-active Peptides Market Drivers & Opportunity
Table 3. Bio-active Peptides Market Challenges
Table 4. Bio-active Peptides Market Restraints
Table 5. Global Bio-active Peptides Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Bio-active Peptides Revenue Market Share by Company (2019-2024)
Table 7. Global Bio-active Peptides Sales Volume by Company (2019-2024) & (Ton)
Table 8. Global Bio-active Peptides Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Bio-active Peptides Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Bio-active Peptides Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Bio-active Peptides Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Bio-active Peptides
Table 13. Global Bio-active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-active Peptides as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Bio-active Peptides Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Bio-active Peptides Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Bio-active Peptides Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Bio-active Peptides Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Bio-active Peptides Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Bio-active Peptides Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)
Table 22. Global Bio-active Peptides Sales Volume by Type (2019-2024) & (Ton)
Table 23. Global Bio-active Peptides Sales Volume by Type (2025-2030) & (Ton)
Table 24. Global Bio-active Peptides Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Bio-active Peptides Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Bio-active Peptides Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Bio-active Peptides Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Bio-active Peptides Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Bio-active Peptides Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Bio-active Peptides Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Bio-active Peptides Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Bio-active Peptides Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Bio-active Peptides Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)
Table 34. Global Bio-active Peptides Sales Volume by Application (2019-2024) & (Ton)
Table 35. Global Bio-active Peptides Sales Volume by Application (2025-2030) & (Ton)
Table 36. Global Bio-active Peptides Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Bio-active Peptides Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Bio-active Peptides Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Bio-active Peptides Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Bio-active Peptides Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Bio-active Peptides Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Bio-active Peptides Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Bio-active Peptides Sales Value by Region (2019-2024) & (%)
Table 44. Global Bio-active Peptides Sales Value by Region (2025-2030) & (%)
Table 45. Global Bio-active Peptides Sales Volume by Region (Ton): 2019 VS 2023 VS 2030
Table 46. Global Bio-active Peptides Sales Volume by Region (2019-2024) & (Ton)
Table 47. Global Bio-active Peptides Sales Volume by Region (2025-2030) & (Ton)
Table 48. Global Bio-active Peptides Sales Volume by Region (2019-2024) & (%)
Table 49. Global Bio-active Peptides Sales Volume by Region (2025-2030) & (%)
Table 50. Global Bio-active Peptides Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Bio-active Peptides Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Bio-active Peptides Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Bio-active Peptides Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Bio-active Peptides Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Bio-active Peptides Sales Volume, (2019-2024) & (Ton)
Table 56. Key Countries/Regions Bio-active Peptides Sales Volume, (2025-2030) & (Ton)
Table 57. Archer Daniels Midland Company Company Information
Table 58. Archer Daniels Midland Company Introduction and Business Overview
Table 59. Archer Daniels Midland Company Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Archer Daniels Midland Company Bio-active Peptides Product Offerings
Table 61. Archer Daniels Midland Company Recent Development
Table 62. Seagarden AS Company Information
Table 63. Seagarden AS Introduction and Business Overview
Table 64. Seagarden AS Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Seagarden AS Bio-active Peptides Product Offerings
Table 66. Seagarden AS Recent Development
Table 67. Phermpep Company Information
Table 68. Phermpep Introduction and Business Overview
Table 69. Phermpep Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Phermpep Bio-active Peptides Product Offerings
Table 71. Phermpep Recent Development
Table 72. Arlak Biotech Company Information
Table 73. Arlak Biotech Introduction and Business Overview
Table 74. Arlak Biotech Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Arlak Biotech Bio-active Peptides Product Offerings
Table 76. Arlak Biotech Recent Development
Table 77. Naturade Company Information
Table 78. Naturade Introduction and Business Overview
Table 79. Naturade Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Naturade Bio-active Peptides Product Offerings
Table 81. Naturade Recent Development
Table 82. Royal DSM Company Information
Table 83. Royal DSM Introduction and Business Overview
Table 84. Royal DSM Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Royal DSM Bio-active Peptides Product Offerings
Table 86. Royal DSM Recent Development
Table 87. MYOS RENS Technology Company Information
Table 88. MYOS RENS Technology Introduction and Business Overview
Table 89. MYOS RENS Technology Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. MYOS RENS Technology Bio-active Peptides Product Offerings
Table 91. MYOS RENS Technology Recent Development
Table 92. Natural Factors Nutritional Products Company Information
Table 93. Natural Factors Nutritional Products Introduction and Business Overview
Table 94. Natural Factors Nutritional Products Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Natural Factors Nutritional Products Bio-active Peptides Product Offerings
Table 96. Natural Factors Nutritional Products Recent Development
Table 97. Valio Oy Company Information
Table 98. Valio Oy Introduction and Business Overview
Table 99. Valio Oy Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Valio Oy Bio-active Peptides Product Offerings
Table 101. Valio Oy Recent Development
Table 102. Wuhan Lullaby Pharmaceutical Chemical Company Information
Table 103. Wuhan Lullaby Pharmaceutical Chemical Introduction and Business Overview
Table 104. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Offerings
Table 106. Wuhan Lullaby Pharmaceutical Chemical Recent Development
Table 107. Wuhan Dahua Pharmaceutical Company Information
Table 108. Wuhan Dahua Pharmaceutical Introduction and Business Overview
Table 109. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. Wuhan Dahua Pharmaceutical Bio-active Peptides Product Offerings
Table 111. Wuhan Dahua Pharmaceutical Recent Development
Table 112. Pharma Foods International Company Information
Table 113. Pharma Foods International Introduction and Business Overview
Table 114. Pharma Foods International Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Pharma Foods International Bio-active Peptides Product Offerings
Table 116. Pharma Foods International Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Bio-active Peptides Downstream Customers
Table 120. Bio-active Peptides Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-active Peptides Product Picture
Figure 2. Global Bio-active Peptides Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Bio-active Peptides Sales Volume (2019-2030) & (Ton)
Figure 5. Global Bio-active Peptides Sales Price (2019-2030) & (US$/Ton)
Figure 6. Bio-active Peptides Report Years Considered
Figure 7. Global Bio-active Peptides Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Bio-active Peptides Players Sales Volume Ranking (2023) & (Ton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-active Peptides Revenue in 2023
Figure 10. Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Natural Bio-active Peptides Picture
Figure 12. Artificial Synthesis Bio-active Peptides Picture
Figure 13. Global Bio-active Peptides Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Bio-active Peptides Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Bio-active Peptides Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)
Figure 16. Global Bio-active Peptides Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Bio-active Peptides Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Food
Figure 19. Product Picture of Health Products
Figure 20. Product Picture of Pharmaceutical
Figure 21. Product Picture of Other
Figure 22. Global Bio-active Peptides Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Bio-active Peptides Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Bio-active Peptides Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)
Figure 25. Global Bio-active Peptides Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Bio-active Peptides Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Bio-active Peptides Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Bio-active Peptides Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Bio-active Peptides Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Bio-active Peptides Sales Volume (%), (2019-2030)
Figure 39. United States Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 45. China Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 47. China Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 57. India Bio-active Peptides Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Bio-active Peptides Sales Value by Type (%), 2023 VS 2030
Figure 59. India Bio-active Peptides Sales Value by Application (%), 2023 VS 2030
Figure 60. Bio-active Peptides Industrial Chain
Figure 61. Bio-active Peptides Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Bio-active Peptides market?
The top companies in the global Bio-active Peptides market are Archer Daniels Midland Company、Seagarden AS、Phermpep.
Related Reports
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-active Peptides was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 143
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2026
The global Bio-active Peptides market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 136
USD 2900.00
(Single User License)
Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 157
USD 4900.00
(Single User License)
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 114
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-04-08
Pages: 113
USD 4900.00
(Single User License)
Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-01-16
Pages: 100
USD 2900.00
(Single User License)
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-active Peptides was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 143
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2026
The global Bio-active Peptides market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 136
USD 2900.00 (Single User License)Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 157
USD 4900.00 (Single User License)Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 114
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 96
USD 2900.00 (Single User License)Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-04-08
Pages: 113
USD 4900.00 (Single User License)Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-01-16
Pages: 100
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now